original ) (raw )Interaction of antidepressants with 4-aminopyridine
Alessandro Lecci
Life Sciences, 1992
View PDFchevron_right
Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats
Magdalena Jastrzębska-więsek
Naunyn-Schmiedeberg's Archives of Pharmacology
View PDFchevron_right
Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist
Luigi Cervo
European Journal of Pharmacology, 1987
View PDFchevron_right
(R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists
Tommy Lewander
European Journal of Pharmacology, 1993
View PDFchevron_right
Sedative/anxiolytic effects of antidepressants in animals
jerry M cott
Acta Psychiatrica Scandinavica, 1981
View PDFchevron_right
A-80426, A Potent and Selective a,-Adrenoceptor Antagonist With Serotonin Uptake-Blocking Activity and Putative Antidepressant-Like Effects: 11. Pharmacology Profile I NTRODUCTI ON
Joseph Wettstein
View PDFchevron_right
Preclinical evidence for the anxiolytic activity of 5-HT3 receptor antagonists: A review
Berend Olivier
Stress Medicine, 1992
View PDFchevron_right
A-80426, a potent and selective ?2-adrenoceptor antagonist with serotonin uptake-blocking activity and putative antidepressant-like effects: II. Pharmacology profile
Joseph Wettstein
Drug Development Research, 1995
View PDFchevron_right
LY367265, an inhibitor of the 5-hydroxytryptamine transporter and 5-hydroxytryptamine2A receptor antagonist: a comparison with the antidepressant, nefazodone
Stephen Carney
European Journal of Pharmacology, 2000
View PDFchevron_right
Anxiolytic-Like Effects of Antidepressants After Acute Administration in a Four-Plate Test in Mice
Michel Bourin
Pharmacology Biochemistry and Behavior, 2000
View PDFchevron_right
Further analysis of the specificity of a novel animal model of depression—effects of an antihistaminic, antipsychotic and anxiolytic compound
Richard Katz
Pharmacology Biochemistry and Behavior, 1982
View PDFchevron_right
A Behavioural and Biochemical Study in Rats of 5-HYDROXYTRYPTAMINE Receptor Agonists and Antagonists, with Observations on Structure-Activity Requirements for the Agonists
Anthony Rees
British Journal of Pharmacology, 1981
View PDFchevron_right
Chronic Treatment with Antidepressant Drugs and ECT Differentially Modifies the Hypothermic Action of Clonidine and Guanfacine
T. Archer , Wojciech Danysz
Pharmacology & Toxicology, 1987
View PDFchevron_right
The Effects of 8-Hydroxy-2-(di- n -propylamino)tetralin on the Cholinergic Contraction in Guinea Pig and Human Airways In Vitro
Paul Leyn
American Journal of Respiratory and Critical Care Medicine, 1998
View PDFchevron_right
Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptor
Mark Tricklebank
European Journal of Pharmacology, 1991
View PDFchevron_right
Pharmacology and psychiatry
Edwin Marley
Psychological Medicine, 1972
View PDFchevron_right
The effect of some psychoactive drugs on central monoamine neurons
Tomas Hökfelt
European Journal of Pharmacology, 1967
View PDFchevron_right
Modification of the Anxiolytic Action of 5-HT1A Compounds by GABA–Benzodiazepine Agents in Rats
Carolina López-Rubalcava
Pharmacology Biochemistry and Behavior, 1998
View PDFchevron_right
Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action
Colin T Dourish
View PDFchevron_right
Development of New Antidepressants
Angelo Sambunaris
Advances in Psychiatric Treatment, 1997
View PDFchevron_right
F 11440, a Potent, Selective, High Efficacy 5-HT 1A Receptor Agonist with Marked Anxiolytic and Antidepressant Potential
Karlsson Ek , M. Kleven
View PDFchevron_right
The role of serotonin receptors in the action of atypical antipsychotic drugs
Bill Massey
Current Opinion in Pharmacology, 2011
View PDFchevron_right
Binding of antidepressants to human brain receptors: focus on newer generation compounds
Elliott Richelson
Psychopharmacology, 1994
View PDFchevron_right
Blockade of 5-Hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine
P. Blier
British Journal of Pharmacology, 1998
View PDFchevron_right
Enhancement of imipramine-induced rat brain β-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan
Ali Mustafa
Psychopharmacology, 1991
View PDFchevron_right
A-80426, a potent ?2-adrenoceptor antagonist with serotonin uptake blocking activity and putative antidepressant-like effects: I. Biochemical profile
Mike Williams
Drug Development Research, 1995
View PDFchevron_right
Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test
Michel Bourin
Psychopharmacology, 2005
View PDFchevron_right
Journal of Pharmacology and Experimental Therapeutics
Neil Parrott
View PDFchevron_right
Behavioral effects of the β 3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs
atef mazeed
European Journal of Pharmacology, 2007
View PDFchevron_right
Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice
Michel Bourin
European Neuropsychopharmacology, 2001
View PDFchevron_right
The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-Propylamino) tetralin in the rat
Mark Tricklebank
European Journal of Pharmacology, 1984
View PDFchevron_right
Neurochemical effects of 8-hydroxy-2-di-n-propylamino tetralin in rats treated with haloperidol
Erum Shireen
Pakistan journal of pharmaceutical sciences, 2002
View PDFchevron_right